GLOBALMalwareHealthcareHealthcareRansomwareMedusaRansom DemandedActor NamedData Leak ThreatenedData PublishedHigh
Steripharma
bd_6e7c324c8165f0c4 · schema v1 · pii pii-v1
Full breach record for Steripharma →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Medusa on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Group activity: HealthcareDiscovered: 2023-09-11
Source: Ransomware.live
Post text · scraped from the leak site
Steripharma is a Moroccan pharmaceutical laboratory founded in 1999. Cooperates with both public and private clients in Morocco and Africa. The company's head office is located at 429 So. West St, Syracuse, New York 13202, US
Tracked as a single-filing incident — the only disclosure on record for this event so far.Unverified claimView incident
No regulatory filing corroborates this yet. If an SEC 8-K, state-AG notice, or victim statement lands, DisclosureLens will merge it into an incident and link it here.
Source provenance
- Source URL
- https://www.ransomware.live/id/U3RlcmlwaGFybWEgQG1lZHVzYQ==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Sep 11, 2023
- Raw hash
- 3647db9e490a904bebfdeb1d81ea2228f777a654fa9e93c49ad64bc51ce2ea34
Reporting entity
- Name
- medusa
Victim entity
- Name
- Steripharmanorm: steripharma
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· medusa
- Threat actor
- MedusaExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.